#Thinksabio latest news Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder Post navigation Stock price, Description, News & InfoTG Therapeutics, Inc. (TGTX) Stock price, Description, News & Info